Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Results may arrive in time to share and improve %
View:
Comment by Rumpl3StiltSkin on Mar 06, 2021 9:15am
Interesting, maybe 1433/Rutherrin would benefit from this. I do think though that by the time TLT rolls out the Osmium/Iridium PDCs there will be diminishing returns from adding nano particles.
Comment by CancerSlayer on Mar 06, 2021 5:10pm
Regarding the x-ray treatment of deep-seated tumors, what is encouraging about our PDCs is that they seem to be "not" as reliant on the presence of scintillating nanoparticles.  Other PDCs rely significantly on such nanoparticles to first convert the x-ray energy into the activation energy that's needed by the PDC.  As preclinically proven in GBM, TLD-1433 can be " ...more  
Comment by Rumpl3StiltSkin on Mar 07, 2021 9:34am
Thanks CS,  I think once/IF TLT masters how to use x-rays to activate these PDCs it is game over for Cancer, and other big pharma medical aproaches to cancer. There wont be any new PDCs to emerge that will act significanty better that Dr. Sherri's Osmium and Irridium compounds. Should keep TLT in the forrefront of cancer treatment for the forseeable future. C'mon Phase 2 NMIBC ...more  
Comment by Eoganacht on Mar 07, 2021 2:15pm
The future looks bright indeed! If the current trial demonstrates sensational results and the coming X-ray activation trials work out well then this could well be the future of cancer treatment! Unfortunately, given my age and the amount of time these developments take, it could well be a post-Eoganacht future!
Comment by Johnandrose22 on Mar 07, 2021 3:52pm
Say it ain’t so, Eoganacht!....May you be contributing to this board well into your triple digits...both age and stock price!
Comment by StevenBirch on Mar 07, 2021 4:21pm
I second that.
Comment by CancerSlayer on Mar 07, 2021 4:24pm
So moved : )
Comment by Eoganacht on Mar 07, 2021 5:32pm
Thanks fellas. Sure would be nice to see how this turns out.
Comment by BlueFranky on Mar 07, 2021 7:45pm
Count me in as pulling for you, Eoganacht... Your contributions here have been invaluable!
Comment by Rumpl3StiltSkin on Mar 07, 2021 10:08pm
You still thinking this will happen by 2022? That isn't too far for you to see the start of this at least? And Proffit!!!
Comment by Eoganacht on Mar 07, 2021 10:25pm
You're right. I was thinking about whether or not Theralase will become a major player in cancer treatment in general rather than being able to commercialize a treatment for BCG unresponsive NMIBC. Yeah, I think we'll all be rich in 2022!
Comment by enriquesuave on Mar 07, 2021 10:36pm
Amen to that, but I personally think that we will be rich this year and even richer in 2022.  
Comment by Eoganacht on Mar 07, 2021 11:03pm
Amen to that! :)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250